ARK Genomic Revolution ETF

ARKG · ETF

$48.16+$0.29 (+0.61%)TodayMarket closed ·
Prev close $47.87

About ARKG

ARKG was created on 2014-10-31 by ARK. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 2055.75m in AUM and 34 holdings. ARKG is an actively managed fund that targets companies involved in the genomics industry.

Issuer
ARK
Expense ratio
0.75%
Assets under management
$1.94B
Inception
Oct 31, 2014
Asset class
Equity

ARKG key statistics

Market cap
0
Price-earnings ratio
0.00
Average volume
5.75M
Volume
3.63M
Open price
$47.52
High today
$48.21
Low today
$46.68
52 Week high
$58.83
52 Week low
$24.60

ARK Genomic Revolution ETF (ARKG) at a glance

ARK Genomic Revolution ETF (ARKG) last traded at $48.16, with a market cap of 0 and a price-to-earnings ratio of 0.00.

Today the fund has traded between $46.68 and $48.21. The current price is 3.2% above the day's low and 0.1% below its high.

Volume so far is 3.63M shares, below the average of 5.75M shares a day.

Over the past year ARK Genomic Revolution ETF has ranged from $24.60 to $58.83, and now sits 69% of the way up that range.

ARKG news

  • Chandrima Sanyal

    Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up

  • Chris Katje

    Donald Trump, Cathie Wood Bet on the Same 32 Stocks – Some Might Surprise You

  • Chandrima Sanyal

    Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets

  • Akanksha Bakshi

    Why Is Tempus AI Stock Falling Friday?

  • Chandrima Sanyal

    Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs

  • Vandana Singh

    What’s Going On With Tempus AI Stock on Monday?

  • Chandrima Sanyal

    Merck, Moderna Cancer Vaccine Breakthrough Could Be Catalyst the mRNA ETF Trade Has Been Waiting For

  • Chandrima Sanyal

    Cathie Wood Swaps Robinhood for SpaceX, Archer—Did ARK Pivot Back to Moonshot Innovation?

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.